Few drugs in history have generated as much controversy as MDMA—or held as much promise, according to some. Once vilified as a Schedule I substance that would supposedly eat holes in users’ brains, MDMA (also known as Molly or Ecstasy) is now being hailed as a therapeutic agent that could transform the field of mental health and outpace psilocybin and ketamine as the first psychedelic approved for widespread clinical use.
Award-winning science journalist Rachel Nuwer separates fact from fantasy, hope from hype, in the drug’s contested history and still-evolving future. Hear more as Nuwer explains the cultural and scientific upheaval that is rewriting our understanding of our brains, our selves, and the space between.

This program contains EXPLICIT content.
Learn more about your ad choices. Visit megaphone.fm/adchoices